Please login to the form below

Verona Pharma

This page shows the latest Verona Pharma news and features for those working in and with pharma, biotech and healthcare.

Vernalis accepts £33m takeover offer from Ligand Pharma

Biotech buyout brings team of 70 scientists in Cambridge, UK. After mulling over several takeover offers, UK biotech Vernalis has been won over by an overture from California’s Ligand Pharma ... Clinical-stage pipeline projects include Verona

Latest news

The power of small

Putting his money where his mouth is, Trevor joined Verona Pharma, a small, start-up biotech, as non-executive director of the board in September 2006. ... The Author. Michael Walker, PhD is chief executive officer and co-founder of Verona Pharma.
Malcolm's Market Eye: 6 to 12 October 2007

Verona Pharma may have secured go ahead for chronic respiratory drug. ... Verona Pharma, the life sciences company, is focusing on therapeutic drugs with which to treat asthma, hay- fever and other chronic respiratory ailments.

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

Verona Pharma appoints chief medical officer. Clinical stage biopharma Verona Pharma has boosted its team with the appointment of Kathleen Rickard. ... Prior to joining Verona Pharma, she was a strategic drug development leader at IQVIA where she helped
Dr Desiree Luthman joins Verona Pharma

She takes up its vice president position. UK-based clinical stage biopharma company Verona Pharma has appointed Dr Desiree Luthman as its vice president of regulatory affairs. ... Jan-Anders Karlsson, chief executive officer of Verona Pharma, said: “We
Verona Pharma strengthens senior management team

Richard Hennings joins as commercial director. Verona Pharma has appointed Richard Hennings in a role that will see him oversee the firm’s marketing access strategy and increase its commercial focus. ... Jan-Anders Karlsson, CEO of Verona Pharma, said:
Mereo BioPharma’s Richard Bungay to step down

He has previously held the chief financial title at Glide Pharmaceutical Technologies, Chroma Therapeutics and Verona Pharma, remaining as a non-executive board director at both Glide and Chroma.
Vikas Sinha joins Verona as non-executive director

UK drug development company Verona Pharma has appointed Vikas Sinha as a non-executive director. ... Dr David Ebsworth, chairman of Verona Pharma, said: “Vikas' impressive financial background, including his US expertise, makes him a very welcome